"Memantine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
AMANTADINE derivative that has some dopaminergic effects. It has been proposed as an antiparkinson agent.
Below are MeSH descriptors whose meaning is more general than "Memantine".
Below are MeSH descriptors whose meaning is more specific than "Memantine".
This graph shows the total number of publications written about "Memantine" by people in this website by year, and whether "Memantine" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Memantine" by people in Profiles.
Memantine treatment of trichotillomania. Ann Clin Psychiatry. 2020 05 01; 32(2):144-145.
Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001. J Clin Oncol. 2020 04 01; 38(10):1019-1029.
GRIN2B encephalopathy: novel findings on phenotype, variant clustering, functional consequences and treatment aspects. J Med Genet. 2017 07; 54(7):460-470.
Memantine reduces stealing behavior and impulsivity in kleptomania: a pilot study. Int Clin Psychopharmacol. 2013 Mar; 28(2):106-11.
Telescoping phenomenon in pathological gambling: association with gender and comorbidities. J Nerv Ment Dis. 2012 Nov; 200(11):996-8.
Open-label pilot study of memantine in the treatment of compulsive buying. Ann Clin Psychiatry. 2012 May; 24(2):119-26.
AMPA workshop on challenges faced by investigators conducting Alzheimer's disease clinical trials. Alzheimers Dement. 2011 Jul; 7(4):e109-17.
Memantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: a pilot study. Psychopharmacology (Berl). 2010 Dec; 212(4):603-12.
A prospective, open-label trial of memantine in the treatment of cognitive, behavioral, and memory dysfunction in pervasive developmental disorders. J Child Adolesc Psychopharmacol. 2006 Oct; 16(5):517-24.